Fate Therapeutics Stock Market Value
| FATE Stock | USD 2.07 0.15 6.76% |
| Symbol | Fate |
Fate Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.123 | Quarterly Revenue Growth 0.581 | Return On Assets (0.22) | Return On Equity (0.47) |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fate Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fate Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fate Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Fate Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Fate Therapeutics or generate 0.0% return on investment in Fate Therapeutics over 30 days. Fate Therapeutics is related to or competes with Atara Biotherapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, Intellia Therapeutics, Editas Medicine, and Crispr Therapeutics. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for ca... More
Fate Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fate Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fate Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 22.4 | |||
| Value At Risk | (7.47) | |||
| Potential Upside | 8.3 |
Fate Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fate Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fate Therapeutics' standard deviation. In reality, there are many statistical measures that can use Fate Therapeutics historical prices to predict the future Fate Therapeutics' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.07) | |||
| Total Risk Alpha | (1.49) | |||
| Treynor Ratio | (0.38) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fate Therapeutics Backtested Returns
Fate Therapeutics secures Sharpe Ratio (or Efficiency) of -0.17, which denotes the company had a -0.17% return per unit of risk over the last 3 months. Fate Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fate Therapeutics' Mean Deviation of 3.94, standard deviation of 4.93, and Variance of 24.27 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.23, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fate Therapeutics will likely underperform. At this point, Fate Therapeutics has a negative expected return of -0.86%. Please make sure to confirm Fate Therapeutics' skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Fate Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Fate Therapeutics has modest predictability. Overlapping area represents the amount of predictability between Fate Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fate Therapeutics price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Fate Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Fate Therapeutics lagged returns against current returns
Autocorrelation, which is Fate Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fate Therapeutics' stock expected returns. We can calculate the autocorrelation of Fate Therapeutics returns to help us make a trade decision. For example, suppose you find that Fate Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Fate Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fate Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fate Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fate Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Fate Therapeutics Lagged Returns
When evaluating Fate Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fate Therapeutics stock have on its future price. Fate Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fate Therapeutics autocorrelation shows the relationship between Fate Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Fate Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fate Therapeutics is a strong investment it is important to analyze Fate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fate Therapeutics' future performance. For an informed investment choice regarding Fate Stock, refer to the following important reports:Check out Fate Therapeutics Correlation, Fate Therapeutics Volatility and Fate Therapeutics Alpha and Beta module to complement your research on Fate Therapeutics. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.